A neoteric annotation on the advances in combination therapy for Parkinson's disease: nanocarrier-based combination approach and future anticipation. Part II …
Introduction The current treatment modalities available for Parkinson's disease (PD) prove
inadequate due to the inherent constraints in effectively transporting bioactive compounds …
inadequate due to the inherent constraints in effectively transporting bioactive compounds …
Application of CRISPR/Cas9 System in the Treatment of Alzheimer's Disease and Neurodegenerative Diseases
A Rahimi, P Sameei, S Mousavi, K Ghaderi… - Molecular …, 2024 - Springer
Abstract Alzheimer's, Parkinson's, and Huntington's are some of the most common
neurological disorders, which affect millions of people worldwide. Although there have been …
neurological disorders, which affect millions of people worldwide. Although there have been …
Experimental validation of Vitex negundo leaves hydroalcoholic extract for neuroprotection in haloperidol induced parkinson's disease in rat
A Vannur, PR Biradar, V Patil - Metabolic Brain Disease, 2022 - Springer
Parkinsonism is a neurodegenerative disease, mainly imbalance in dopamine and
acetylcholine neurotransimitter in mid brain, which manifestation of dysfunctions of …
acetylcholine neurotransimitter in mid brain, which manifestation of dysfunctions of …
Mucuna pruriens vs. Morbus Parkinson: Making the case for medicinal supplements within Medicinal Agroecology
IN Fiebrig, M Van de Vijver, CJ van Kan - Medicinal Agroecology, 2023 - library.oapen.org
This current chapter reports an initially singular case of a PD patient in Germany who could
not be treated with conventional PD medication and whose quality of life had deteriorated …
not be treated with conventional PD medication and whose quality of life had deteriorated …
[PDF][PDF] Assessment of Neuropathological Findings and Medical Treatment of Parkinson Disease: A Review of Literature
RA Abdullah - Ann Coll Med Mosul June, 2022 - scholar.archive.org
Background: Parkinson disease is a long-lasting and progressive motor disorder which is
identified by three critical motor symptoms which are bradykinesia, rigidity and tremor. Aim of …
identified by three critical motor symptoms which are bradykinesia, rigidity and tremor. Aim of …
[PDF][PDF] Agonistes dopaminergiques et effets indésirables neuropsychiatriques lors de la prise en charge de la Maladie de Parkinson: prise en charge à l'officine
M Anthony - pepite-depot.univ-lille.fr
La maladie de Parkinson (MP) est une maladie chronique progressive qui touche le
système nerveux central. Cette maladie neurodégénérative se caractérise par des …
système nerveux central. Cette maladie neurodégénérative se caractérise par des …